Boosting BCG-primed mice with chimeric DNA vaccine HG856A induces potent multifunctional T cell responses and enhanced protection against Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Boosting BCG-primed mice with chimeric DNA vaccine HG856A induces potent multifunctional T cell responses and enhanced protection against Mycobacterium tuberculosis

Published:2015-06-26 Issue:1 Volume:64 Page:64-72
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Ji Ping,Hu Zhi-Dong,Kang Han,Yuan Qin,Ma Hui,Wen Han-li,Wu Juan,Li Zhong-Ming,Lowrie Douglas B.,Fan Xiao-Yong

Funder

Chinese National Mega Scienology Program on Infectious Diseases

National Science Foundation of China

Shanghai Science and Technology Commission of Shanghai Municipality

Shanghai Science and Technology Commission

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1007/s12026-015-8674-9.pdf

Reference42 articles.

1. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA. 1994;271:698–702.

2. Dalmia N, Ramsay AJ. Prime-boost approaches to tuberculosis vaccine development. Expert Rev Vaccines. 2012;11:1221–33.

3. Brennan MJ, Clagett B, Fitzgerald H, Chen V, Williams A, Izzo AA, et al. Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis. Vaccine. 2012;30:2811–23.

4. Tyagi AK, Nangpal P, Satchidanandam V. Development of vaccines against tuberculosis. Tuberculosis (Edinb). 2011;91:469–78.

5. Zuniga J, Torres-Garcia D, Santos-Mendoza T, Rodrigue-Reyna TS, Granados J, Yunis EJ. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol. 2012;2012:193923.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis;Emerging Microbes & Infections;2024-01-04

2. Heterologous prime-boost BCG with DNA vaccine expressing fusion antigens Rv2299c and Ag85A improves protective efficacy against Mycobacterium tuberculosis in mice;Frontiers in Microbiology;2022-10-04

3. A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19;Frontiers in Immunology;2022-08-26

4. Enhanced immunogenicity of the tuberculosis subunit Rv0572c vaccine delivered in DMT liposome adjuvant as a BCG-booster;Tuberculosis;2022-05

5. Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines;Journal of Molecular Medicine;2019-11-30